Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

OBJECTIVE: The addition of bevacizumab to fluoropyrimidine-based combination chemotherapy as first-line therapy for metastatic colorectal cancer results in clinically significant improvements in patient outcome. However, clinical trials have been conducted primarily in Caucasian patients with only a...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Toshihiko, Boku, Narikazu, Kato, Ken, Komatsu, Yoshito, Yamaguchi, Kensei, Muro, Kei, Hamamoto, Yasuo, Sato, Atsushi, Koizumi, Wasaburo, Mizunuma, Nobuyuki, Takiuchi, Hiroya
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947844/
https://www.ncbi.nlm.nih.gov/pubmed/20462981
http://dx.doi.org/10.1093/jjco/hyq069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947844/
https://www.ncbi.nlm.nih.gov/pubmed/20462981
http://dx.doi.org/10.1093/jjco/hyq069

Ejemplares similares